trending Market Intelligence /marketintelligence/en/news-insights/trending/W67ZOhqr5EFFT0XYZRHi9Q2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

US trade group challenges CMS over reimbursement rates for lab tests

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


US trade group challenges CMS over reimbursement rates for lab tests

The American Clinical Laboratory Association filed a lawsuit in the U.S. District Court for the District of Columbia, challenging the process by which the Centers for Medicare & Medicaid Services, or CMS, set reimbursement rates for lab tests for 2018.

The ACLA argued in its lawsuit that CMS failed to implement a market-based laboratory payment system by prohibiting an "overwhelming majority" of laboratories from reporting private payer data.

The new reimbursement system will reduce how much Medicare pays for labs by about $670 million in 2018, according to the lawsuit which names Eric Hargan, the acting U.S. secretary for the Department of Health and Human Services, as defendant.

Laboratory Corp. of America Holdings and Quest Diagnostics Inc., which previously criticized the new pricing structure, issued statements in support of the lawsuit.